Posterior Vitreous Detachment - Symptoms, Causes, Treatment & Prevention

```html

Overview

Posterior vitreous detachment (PVD) is a common, usually benign, age‑related change in the eye in which the vitreous body—a clear, gel‑like substance that fills the back of the eye—separates from the retina. The vitreous is attached to the retina at several points, most notably at the optic disc and along the vascular arches. Over time, the gel liquefies (a process called syneresis) and loses its adherence, eventually pulling away from the retinal surface.

Who it affects

• Adults ≥ 50 years old (≈ 70‑80 % of people over 65 experience PVD)
• Individuals with high myopia (nearsightedness) are up to 2‑3 times more likely to develop PVD earlier.
• People who have undergone cataract surgery, ocular trauma, or have inflammatory eye disease have a modestly increased risk.

Prevalence – The U.S. National Eye Institute estimates that about 1 in 2 adults older than 65 will have a PVD by age 70. While most cases are asymptomatic, up to 30 % notice visual disturbances that prompt an eye‑care visit.

Symptoms

Symptoms arise when the vitreous tugs on the retina or when tiny retinal blood vessels break. Not everyone experiences all of them.

• Flashes of light (photopsia) – brief, lightning‑bolt‑like streaks, usually in the peripheral visual field.
• Floaters – small, dark, cobweb‑like shapes that drift with eye movements. They may appear as dots, threads, or “black flies.”
• Shadow or curtain‑like loss of vision – indicates that the vitreous is pulling on or has created a retinal tear; this is an emergency.
• Blurred or distorted vision – can result from large aggregates of vitreous collagen or from accompanying retinal pathology.
• Reduced night vision – due to increased scattering of light by floaters.
• Eye discomfort or a sensation of “something in the eye” – not pain, but a vague awareness.

Causes and Risk Factors

Physiologic cause

The vitreous is composed of ~99 % water, collagen fibrils, and hyaluronic acid. With age, the collagen network contracts and the gel “liquefies.” This changes the shape of the vitreous cavity, creating traction on the retinal attachment sites. When traction exceeds adhesion strength, detachment occurs.

Key risk factors

• Age – The single strongest predictor; prevalence rises sharply after age 50.
• High myopia (≥ ‑6.00 D) – Longer axial length stretches the vitreous and retina.
• Previous ocular surgery – Cataract extraction can alter vitreous dynamics.
• Ocular trauma – Direct injury can precipitate early detachment.
• Inflammatory eye disease (e.g., uveitis) – Inflammation weakens vitreoretinal adhesion.
• Systemic connective‑tissue disorders such as Marfan syndrome or Ehlers‑Danlos (rare).

Diagnosis

Diagnosis is primarily clinical, performed by an eye‑care professional (optometrist or ophthalmologist).

History & symptom review

The clinician asks about onset, character of flashes or floaters, and any visual field loss.

Slit‑lamp examination

A high‑intensity microscope with a bright light allows the doctor to see the vitreous humor and any retinal changes.

Fundus (retinal) examination

Using a dilating eye drop, the practitioner visualizes the retina with an ophthalmoscope or a specialized wide‑field retinal camera. Findings suggestive of PVD include:

• Posterior vitreous cortex separated from the retinal surface.
• “Weiss ring” – a circular opacity formed when the posterior hyaloid separates around the optic disc.
• Peripheral retinal tears or lattice degeneration (often co‑existing).

Imaging studies (when needed)

• Optical Coherence Tomography (OCT) – Provides cross‑sectional images of the vitreoretinal interface; useful for detecting subtle traction or macular involvement.
• Ultrasound B‑scan – Helpful if media opacity (e.g., dense cataract) blocks direct view of the retina.

Treatment Options

In most cases, PVD itself does not require treatment; the vitreous will eventually clear, and floaters often become less bothersome over months.

When observation is sufficient

• Absence of retinal tears, detachment, or macular involvement.
• Patient reassurance and education about warning signs.

Medical management

• Topical or oral anti‑inflammatory agents – Rarely prescribed; may be used if there is concurrent uveitis.
• Laser vitreolysis – A Nd:YAG laser can fragment dense, symptomatic floaters. Evidence from the International Journal of Retina & Vitreous (2022) shows modest improvement in patient‑reported visual quality, but the procedure carries a small risk of retinal damage; it should be performed by an experienced retina specialist.

Surgical options

• Pars plana vitrectomy (PPV) – Minimally invasive surgery that removes the bulk of the vitreous gel and floating debris. Indicated for:
  • Severe, disabling floaters that affect daily activities.
  • Complications such as a retinal tear or detachment.
  Recovery is typically 4‑6 weeks; the risk of cataract formation or intra‑ocular pressure rise is ~10‑15 %.

Lifestyle and self‑care measures

• Maintain good lighting when reading or using screens to reduce the impact of floaters.
• Use anti‑glare glasses or sunglasses outdoors.
• Stay hydrated; dehydration can temporarily intensify floaters.

Living with Posterior Vitreous Detachment

Most people adapt quickly. Here are practical tips:

• Give it time. Floaters often settle after 6‑12 weeks as the vitreous stabilizes.
• Eye‑movement exercises. Slowly moving eyes up‑down and left‑right for a few seconds each can help disperse floaters, though evidence is anecdotal.
• Limit screen glare. Adjust display brightness and use blue‑light filters.
• Regular eye exams. Annual dilated retinal exams are recommended for anyone with a PVD to monitor for retinal tears.
• Protective eyewear. In activities with a risk of eye injury (e.g., sports, woodworking), wear safety glasses.

Prevention

Because PVD is largely age‑related, total prevention is impossible, but certain measures may delay onset or reduce severity:

• Control myopia. Early‑life optical interventions (e.g., atropine eye drops, orthokeratology) have been shown to slow axial elongation, lowering the risk of early PVD.
• Manage systemic health. Good control of hypertension and diabetes reduces the risk of retinal vascular changes that can aggravate vitreoretinal traction.
• Avoid smoking. Smoking is linked to earlier cataract formation and may affect vitreous health.
• Protect eyes from trauma. Wear appropriate protective equipment during sports or high‑risk work.

Complications

While PVD itself is benign, it can precipitate serious ocular problems if the vitreous traction creates a retinal tear.

• Retinal tear – Occurs in ~10‑15 % of PVD cases. Prompt laser photocoagulation can seal the tear and prevent detachment.
• Rhegmatogenous retinal detachment (RRD) – A tear allows fluid to accumulate under the retina. Incidence after PVD is approximately 0.5‑1 % but rises to 5‑10 % when a tear is present.
• Macular hole – Traction at the central retina can lead to a full‑thickness defect, causing central vision loss.
• Vitreous hemorrhage – If traction ruptures retinal vessels, blood can fill the vitreous cavity, causing a sudden “curtain” of dark material.
• Persistent, disabling floaters – In a minority, dense vitreous condensates do not clear and significantly impair visual function.

When to Seek Emergency Care

References

1. Mayo Clinic. Posterior vitreous detachment. https://www.mayoclinic.org (accessed 12 June 2026).

2. National Eye Institute. “Age-Related Changes in the Eye.” NIH, 2023. https://www.nei.nih.gov.

3. American Academy of Ophthalmology. “Posterior Vitreous Detachment Preferred Practice Pattern.” 2022.

4. International Journal of Retina & Vitreous. “Laser Vitreolysis for Symptomatic Floaters: A Systematic Review.” 2022;8:15. DOI:10.1186/s40942‑022‑00367‑x.

5. WHO. “Vision Impairment and Blindness.” Fact sheet, 2021.

```